Business
ChromaDex to Participate in Panel on Master Files for Dietary Supplements Hosted by the American Conference Institute (ACI) and Council for Responsible Nutrition (CRN)
ChromaDex joins industry leaders to discuss “What New Dietary Ingredient Master Files Mean for Innovation & Compliance” LOS ANGELES--(BUSINESS WIRE)--
About this update from Niagen Bioscience, Inc.
[{"type":"text","content":"\nChromaDex joins industry leaders to discuss “What New Dietary Ingredient Master Files Mean for Innovation & Compliance”\n\n LOS ANGELES--(BUSINESS WIRE)--\nChromaDex Corp. (NASDAQ:CDXC) today announced its participation in a panel discussion titled “What New Dietary Ingredient Master Files Mean for Innovation & Compliance,” hosted by the American Conference Institute (ACI) and Council for Responsible Nutrition (CRN). As the global leader in NAD+ science, ChromaDex maintains three New Dietary Ingredient (NDI) notifications from the Food & Drug Administration (FDA) for its proprietary Niagen® (nicotinamide riboside) ingredient and has obtained further regulatory approval in Canada, the European Union, and Australia.\n\n\nChromaDex Co-Founder & Executive Chairman Frank Jaksch will join the panel with Scott Bass, Partner at Sidley Austin LLP and one of the key writers behind the Dietary Supplement Health and Education Act of 1994 (DSHEA); Steve Mister, President & CEO of CRN; and William Turney, Head of Regulatory Affairs and Product Quality Management, DSM Nutritional Products LLC.\n\n\n“We are pleased to join ACI and CRN in the quest for greater transparency, compliance, and enforcement in the dietary supplement industry,” says ChromaDex CEO Rob Fried. “In the interest of public safety, more enforcement is necessary—from claims substantiation to new dietary ingredient notifications.”\n\n\n“The development of master files for new dietary ingredients can spur innovation among dietary supplement manufacturers by protecting their investments in research and by helping the FDA monitor compliance with the requirements for new dietary ingredients,” says Steve Mister, President & CEO of CRN. “As an innovator in the supplement industry, ChromaDex has direct experience with developing a strong safety profile for its ingredient, Niagen, and protecting the intellectual property behind it.”\n\n\nThe live webinar will take place today, Wednesday, May 27, 2020, from 1:00 to 2:00 PM Eastern Time. The webinar will offer expert insight from industry thought leaders to share ideas in the dietary supplement space.\n\n\nThe informative webinar will address the topic of master files for dietary supplements in providing clarity on NDI filing requirements, including:\n\n\n\nWhat will a new dietary ingredient master file look like?\n\n\nHow will master ...